# Codex Review: medical_monitoring_assurance_remediation_preview_20260803

Date: 2026-08-03
Delegated-agent output: not dispatched; direct Codex implementation. The runner report path remains unused.

## Verdict

**accepted_for_offline_code_scope**

## Boundary Check

- No Hermes worker was dispatched; this was a direct Codex implementation. Changes are limited to the workbench assurance feature, its existing panel seam, derived `frontend/dist` output and task evidence records.
- No backend/API, task state, risk/disposition, rollup/conservation, runtime store, B6/C14, source-token/CAS, medical-writing, service, browser, provider or real-project state changed.
- Focus buttons only reuse existing subject/profile/site focus callbacks; no disposition or task transition is issued.

## Codex Verification

- Focused `medicalMonitoringAssuranceRemediation` model: **23 assertions passed**.
- `node --test frontend/src/features/medical-monitoring/*.test.mjs`: **28/28 files passed**.
- `frontend`: `npm run build` passed; **1942 modules transformed**. Existing >500 kB chunk advisory remains.
- Port check: 8911, 5174, 8910 and 4173 were empty.
- Static review confirms matrix entries are sorted deterministically by open status, explicit severity, closure-evidence gap and stable risk instance ID; malformed/duplicate entries remain warnings and are not silently promoted.
- Browser/runtime and real-project checks were intentionally not run because the release dossier and B6/C14 gates remain blocked.

## Delegated-Agent Output Review

- No delegated output to review. Direct Codex preserved the existing conservation banner, assurance task creation gate and read-only wording.
- Omitted rows are explicitly described as still in the current matrix; missing closure evidence is not treated as closure or low clinical risk.

## Residual Risk

The preview has not been exercised in a browser viewport or against a real pre-inspection task. It does not prove matrix completeness, clinical priority, task completion, persistence/restart, Playwright/UAT, B6/C14 activation or commercial release readiness.
